TITLE

HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth

AUTHOR(S)
Pandolfi, S; Montagnani, V; Lapucci, A; Stecca, B
PUB. DATE
December 2015
SOURCE
Cell Death & Differentiation;Dec2015, Vol. 22 Issue 12, p2006
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
HEDGEHOG (HH) signaling is a key regulator of tissue development and its aberrant activation is involved in several cancer types, including melanoma. We and others have shown a reciprocal cross talk between HH signaling and p53, whose function is often impaired in melanoma. Here we present evidence that both GLI1 and GLI2, the final effectors of HH signaling, regulate the transcription factor E2F1 in melanoma cells, by binding to a functional non-canonical GLI consensus sequence. Consistently, we find a significant correlation between E2F1 and PATCHED1 (PTCH1), GLI1 and GLI2 expression in human melanomas. Functionally, we find that E2F1 is a crucial mediator of HH signaling and it is required for melanoma cell proliferation and xenograft growth induced by activation of the HH pathway. Interestingly, we present evidence that the HH/GLI-E2F1 axis positively modulates the inhibitor of apoptosis-stimulating protein of p53 (iASPP) at multiple levels. HH activation induces iASPP expression through E2F1, which directly binds to iASPP promoter. HH pathway also contributes to iASPP function, by the induction of Cyclin B1 and by the E2F1-dependent regulation of CDK1, which are both involved in iASPP activation. Our data show that activation of HH signaling enhances proliferation in presence of E2F1 and promotes apoptosis in its absence or upon CDK1 inhibition, suggesting that E2F1/iASPP dictates the outcome of HH signaling in melanoma. Together, these findings identify a novel HH/GLI-E2F1-iASPP axis that regulates melanoma cell growth and survival, providing an additional mechanism through which HH signaling restrains p53 proapoptotic function.
ACCESSION #
110800630

 

Related Articles

  • Overlapping genetic architecture between Parkinson disease and melanoma. Dube, Umber; Ibanez, Laura; Budde, John P.; Benitez, Bruno A.; Davis, Albert A.; Harari, Oscar; Iles, Mark M.; Law, Matthew H.; Brown, Kevin M.; 23andMe Research Team; Agee, Michelle; Alipanahi, Babak; Auton, Adam; Bell, Robert K.; Bryc, Katarzyna; Elson, Sarah L.; Fontanillas, Pierre; Furlotte, Nicholas A.; Hinds, David A.; Huber, Karen E. // Acta Neuropathologica;Feb2020, Vol. 139 Issue 2, p347 

    Epidemiologic studies have reported inconsistent results regarding an association between Parkinson disease (PD) and cutaneous melanoma (melanoma). Identifying shared genetic architecture between these diseases can support epidemiologic findings and identify common risk genes and biological...

  • Effects of CDKN2A (p16INK4A/p14ARF) Over-Expression on Proliferation and Migration of Human Melanoma A375 Cells. Ming Bai; Nan-Ze Yu; Fei Long; Cheng Feng; Xiao-Jun Wang // Cellular Physiology & Biochemistry (Karger AG);Dec2016, Vol. 40 Issue 3/4, p1367 

    Objective: This study aims to investigate the effects of CDKN2A (p16INK4A/p14ARF) over-expression on the proliferation and migration of human melanoma A375 cells. Methods: Melanoma tissues and pigmented nevi tissues were collected. Human melanoma A375 cells were transfected by CDKN2A (p16INK4A)...

  • Analysis of sequence variants in the 3'UTR of CDKN2A gene in melanoma patients. Przybyła, Anna; Lamperska, Katarzyna; Mackiewicz, Andrzej // Contemporary Oncology / Wspolczesna Onkologia;2015, Vol. 19 Issue 4, p276 

    Background: The 3'UTR region plays a crucial role in regulating gene expression at posttranscriptional levels. Any changes in sequence in this region can cause numerous pathologies and can also lead to tumour development. The most common changes reported in in the CDKN2A gene are the 148Ala/Thr...

  • Increased apoptosis rate of human decidual cells and cytotrophoblasts in patients with recurrent spontaneous abortion as a result of abnormal expression of CDKN1A and Bax. XIAOMEI LV; ZHENHONG CAI; SU LI // Experimental & Therapeutic Medicine;Nov2016, Vol. 12 Issue 5, p2865 

    In the present study, we analyzed the proliferation and apoptosis of trophoblasts and human decidual cells in patients with recurrent spontaneous abortion and the related cellular pathway mechanism. Thirty-four patients with recurrent abortion and 30 healthy pregnant women undergoing planned...

  • Effect of tumor suppressor gene cyclin-dependent kinase inhibitor 2A wild-type and A148T mutant on the cell cycle of human ovarian cancer cells. ZEHUA BIAN; YANG YU; TERIGELE YANG; CHAO QUAN; WENJING SUN; SONGBIN FU // Oncology Letters;2014, Vol. 7 Issue 4, p1229 

    Single-base substitution may affect the function of genes. This study identified a single-base substitution of G for A in codon 148 of cyclin-dependent kinase inhibitor 2A (CDKN2A/p16) by sequencing human ovarian cancer cell line UACC-1598. As a tumor suppressor gene, the expression of...

  • Prevalence of Germline BAP1, CDKN2A, and CDK4 Mutations in an Australian Population-Based Sample of Cutaneous Melanoma Cases. Aoude, Lauren G.; Gartside, Michael; Johansson, Peter; Palmer, Jane M.; Symmons, Judith; Martin, Nicholas G.; Montgomery, Grant W.; Hayward, Nicholas K. // Twin Research & Human Genetics;Apr2015, Vol. 18 Issue 2, p126 

    Mutations in Cyclin-Dependent Kinase Inhibitor 2A (CDKN2A) and Cyclin-Dependent Kinase 4 (CDK4) contribute to susceptibility in approximately 40% of high-density cutaneous melanoma (CMM) families and about 2% of unselected CMM cases. BRCA-1 associated protein-1 (BAP1) has been more recently...

  • Updated evidence‐based clinical practice guidelines for the diagnosis and management of melanoma: definitive excision margins for primary cutaneous melanoma. Sladden, Michael J; Nieweg, Omgo E; Howle, Julie; Coventry, Brendon J; Thompson, John F // Medical Journal of Australia;Feb2018, Vol. 208 Issue 3, p137 

    Introduction: Definitive management of primary cutaneous melanoma consists of surgical excision of the melanoma with the aim of curing the patient. The melanoma is widely excised together with a safety margin of surrounding skin and subcutaneous tissue, after the diagnosis and Breslow thickness...

  • Psychological Impact of Learning CDKN2A Variant Status as a Genetic Research Result. Zhu, Xuan; Leof, Emma R.; Rabe, Kari G.; McCormick, Jennifer B.; Petersen, Gloria M.; Radecki Breitkopf, Carmen // Public Health Genomics;Mar2018, Vol. 21 Issue 3/4, p154 

    Objectives: Little is known about genetic research participants' responses to receiving individual research results (IRR) from cancer genetic research. We examined the immediate and delayed psychological impact of returning a CDKN2A variant result that is associated with increased risk of...

  • Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients. Ciccarese, Giulia; Dalmasso, Bruna; Bruno, William; Queirolo, Paola; Pastorino, Lorenza; Andreotti, Virginia; Spagnolo, Francesco; Tanda, Enrica; Ponti, Giovanni; Massone, Cesare; Drago, Francesco; Parodi, Aurora; Ghigliotti, Giovanni; Pizzichetta, Maria Antonietta; Ghiorzo, Paola; Italian Melanoma Intergroup (I.M.I.) // Journal of Translational Medicine;2/13/2020, Vol. 18 Issue 1, p1 

    Background: The p.E318K variant of the Melanocyte Inducing Transcription Factor (MITF) has been implicated in genetic predisposition to melanoma as an intermediate penetrance allele. However, the impact of this variant on clinico-phenotypic, as well as on dermoscopic patterns...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics